SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-043914
Filing Date
2018-08-13
Accepted
2018-08-13 14:00:15
Documents
52
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv500190_10q.htm 10-Q 329097
2 EXHIBIT 31.1 tv500190_ex31-1.htm EX-31.1 9849
3 EXHIBIT 31.2 tv500190_ex31-2.htm EX-31.2 9682
4 EXHIBIT 32.1 tv500190_ex32-1.htm EX-32.1 5039
5 EXHIBIT 99.1 tv500190_ex99-1.htm EX-99.1 56482
12 GRAPHIC tv500190_img01.jpg GRAPHIC 29304
  Complete submission text file 0001144204-18-043914.txt   4184846

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT fencf-20180630.xml EX-101.INS 1310565
7 XBRL TAXONOMY EXTENSION SCHEMA fencf-20180630.xsd EX-101.SCH 33694
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fencf-20180630_cal.xml EX-101.CAL 17251
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fencf-20180630_def.xml EX-101.DEF 181622
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE fencf-20180630_lab.xml EX-101.LAB 207614
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fencf-20180630_pre.xml EX-101.PRE 203931
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Filer) CIK: 0001211583 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32295 | Film No.: 181011751
SIC: 2836 Biological Products, (No Diagnostic Substances)